1. Home
  2. MRCY vs TMDX Comparison

MRCY vs TMDX Comparison

Compare MRCY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRCY
  • TMDX
  • Stock Information
  • Founded
  • MRCY 1981
  • TMDX 1998
  • Country
  • MRCY United States
  • TMDX United States
  • Employees
  • MRCY N/A
  • TMDX N/A
  • Industry
  • MRCY
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MRCY
  • TMDX Health Care
  • Exchange
  • MRCY Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • MRCY 4.6B
  • TMDX 4.0B
  • IPO Year
  • MRCY 1998
  • TMDX 2019
  • Fundamental
  • Price
  • MRCY $75.33
  • TMDX $125.41
  • Analyst Decision
  • MRCY Buy
  • TMDX Buy
  • Analyst Count
  • MRCY 8
  • TMDX 11
  • Target Price
  • MRCY $72.13
  • TMDX $130.73
  • AVG Volume (30 Days)
  • MRCY 613.1K
  • TMDX 1.1M
  • Earning Date
  • MRCY 11-04-2025
  • TMDX 10-29-2025
  • Dividend Yield
  • MRCY N/A
  • TMDX N/A
  • EPS Growth
  • MRCY N/A
  • TMDX 170.70
  • EPS
  • MRCY N/A
  • TMDX 2.54
  • Revenue
  • MRCY $932,798,000.00
  • TMDX $566,354,000.00
  • Revenue This Year
  • MRCY $6.17
  • TMDX $38.84
  • Revenue Next Year
  • MRCY $8.23
  • TMDX $20.46
  • P/E Ratio
  • MRCY N/A
  • TMDX $49.22
  • Revenue Growth
  • MRCY 8.63
  • TMDX 41.20
  • 52 Week Low
  • MRCY $37.28
  • TMDX $55.00
  • 52 Week High
  • MRCY $85.33
  • TMDX $145.50
  • Technical
  • Relative Strength Index (RSI)
  • MRCY 46.86
  • TMDX 53.22
  • Support Level
  • MRCY $74.07
  • TMDX $119.20
  • Resistance Level
  • MRCY $79.92
  • TMDX $128.09
  • Average True Range (ATR)
  • MRCY 2.71
  • TMDX 7.76
  • MACD
  • MRCY -0.46
  • TMDX -0.37
  • Stochastic Oscillator
  • MRCY 20.53
  • TMDX 36.76

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: